In uterine cancer, recurrent PPP2R1A mutations (P179R and S256F) drive tumorigenesis and metastasis (17), while in colorectal cancer, PPP2R1B (a paralog) inactivation promotes liver metastasis through ERK pathway activation (18). This evidence concerns the gene PPP2R1A and uterine cancer.